<DOC>
	<DOCNO>NCT00330876</DOCNO>
	<brief_summary>This open-label extension study NK-104-306 ( NCT00257686 ) elderly patient hypercholesterolemia combine dyslipidemia .</brief_summary>
	<brief_title>Study Pitavastatin Elderly Patients With Primary Hypercholesterolemia Combined Dyslipidemia</brief_title>
	<detailed_description>This open-label study 60 week duration elderly patient ( â‰¥65 year ) primary hypercholesterolemia combine dyslipidemia complete 12 week treatment study NK-104-306 meet inclusion/exclusion criterion . Patients qualify started open-label treatment pitavastatin 2 mg QD . The dose pitavastatin could increase 4 mg QD least 8 week treatment 2 mg QD , patient fail attain LDL-C target .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Greater equal 65 year age Primary hypercholesterolemia Combined dyslipidemia Completed study NK104306 ( NCT00257686 ) Failed complete study NK104306 ( NCT00257686 )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>pitavastatin</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>combine dyslipidemia</keyword>
</DOC>